ERIC A. LIVESAY, Ph.D.
Eric A. Livesay has been CEO of Hecate since 2014. He served as its Chief Scientific Officer beginning in 2008 when he joined the company. While at Hecate he has worked on various projects in the oil and gas industry as well as the optical industry. He has a strong background in research and development with experience in physics, biotechnology, the life sciences, software development and technology development. From 2003 until 2008 he worked in the proteomics group of Richard Smith first as a post-doctoral researcher and then as a Senior Research Scientist at the Pacific Northwest National Laboratory (PNNL) . At PNNL he was the central resource for the high throughput proteomic analysis effort and focused on the design and development of fully automated capillary liquid chromatography (LC) platforms which were interfaced with a variety of mass spectrometers via electrospray ionization (ESI). From 2000 to 2003, as a post-doctoral researcher, he led an effort at the University of Texas Southwestern Medical Center (UTSW) in the development of a prototype high-throughput DNA synthesizer. He wrote the control software in Visual Basic, interfaced it with various off-the-shelf hardware components (e.g., electromechanical relays and linear motion tables) and also designed and machined several pieces of custom hardware for the prototype. His education includes a B.S. in Physics (1995) and a Ph.D. in Applied Physics (2000) from the University of Texas at Arlington under the supervision of Roy N. West. His dissertation work was the measurement of the Fermi surface of the colossal magnetoresistive material La0.7Sr0.3MnO3 using the method of two-dimensional angular correlation of annihilation radiation (2D-ACAR).